CCL2 -2518 A/G single nucleotide polymorphism as a risk factor for breast cancer

Molecular Biology Reports

Volumn 38, Issue 2, 2011, Pages 1263-1267

  Kruszyna, Łukasz ^a   Lianeri, Margarita ^a   Rubis, Błazej ^a   Knuła, Hanna ^a   Rybczyńska, Maria ^a   Grodecka Gazdecka, Sylwia ^a   Jagodziński, Paweł P ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

Breast cancer; CCL2; Polymorphism

Indexed keywords

ADULT; ARTICLE; BREAST CANCER; CANCER GRADING; CANCER RISK; CCL2 GENE; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC RISK; GENOTYPE; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; POLAND; PREVALENCE; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; TUMOR VOLUME;

AGED; ALLELES; BREAST NEOPLASMS; CHEMOKINE CCL2; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MIDDLE AGED; ODDS RATIO; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; PREVALENCE; RISK FACTORS;

EID: 79951576344     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-010-0225-9     Document Type: Article

References (44)

1. P Parsa B Parsa 2009 Effects of reproductive factors on risk of breast cancer: a literature review Asian Pac J Cancer Prev 10 545 550 19827866
2. P Pisani F Bray DM Parkin 2002 Estimates of the world-wide prevalence of cancer for 25 sites in the adult population Int J Cancer 97 72 81 1:CAS:528:DC%2BD3MXovFKrurk%3D 10.1002/ijc.1571 11774246 (Pubitemid 33104397)
3. T Vargo-Gogola JM Rosen 2007 Modelling breast cancer: one size does not fit all Nat Rev Cancer 7 659 672 1:CAS:528:DC%2BD2sXpsFSjsbw%3D 10.1038/nrc2193 17721431 (Pubitemid 47327411)
4. V Dapic MA Carvalho AN Monteiro 2005 Breast cancer susceptibility and the DNA damage response Cancer Control 12 127 136 15855896 (Pubitemid 40647057)
5. U Veronesi P Boyle A Goldhirsch, et al. 2005 Breast cancer Lancet 365 1727 1741 10.1016/S0140-6736(05)66546-4 15894099 (Pubitemid 40719108)
6. N Bilalović S Vranić F Serdarević, et al. 2006 The role of the stroma in carcinogenesis Bosn J Basic Med Sci 6 33 38 16533177
7. A Mantovani A Sica 2010 Macrophages, innate immunity and cancer: balance, tolerance, and diversity Curr Opin Immunol 22 231 237 1:CAS:528: DC%2BC3cXks1Srtr8%3D 10.1016/j.coi.2010.01.009 20144856
8. C O'Sullivan CE Lewis 1994 Tumour -associated leukocytes: friends or foes in breast carcinoma J Pathol 172 229 235 10.1002/path.1711720302 8195926 (Pubitemid 24151973)
9. BJ Camp ST Dyhrman VA Memoli, et al. 1996 In situ cytokine production by breast cancer tumor-infiltrating lymphocytes Ann Surg Oncol 13 176 184 10.1007/BF02305798 (Pubitemid 126729507)
10. CG Clemente MC Mihm Jr R Bufalino, et al. 1996 Prognostic value of tumor infiltrating lymphocytes in the vertical growth phase of primary cutaneous melanoma Cancer 77 1303 1310 1:STN:280:DyaK287pslChtA%3D%3D 10.1002/(SICI)1097- 0142(19960401)77:7<1303::AID-CNCR12>3.0.CO;2-5 8608507 (Pubitemid 26102328)
11. O Nakano M Sato Y Naito, et al. 2001 Proliferative activity of intratumoral CD8(+) T-lymphocytes as a prognostic factor in human renal cell carcinoma: clinicopathologic demonstration of antitumor immunity Cancer Res 61 5132 5136 1:CAS:528:DC%2BD3MXltVequ7Y%3D 11431351 (Pubitemid 32681545)
12. M Furihata Y Ohtsuki H Sonobe, et al. 1993 Prognostic significance of simultaneous infiltration of HLA-DR-positive dendritic cells and tumor infiltrating lymphocytes into human esophageal carcinoma Tohoku J Exp Med 169 187 195 1:STN:280:DyaK2c%2FmvFCqug%3D%3D 10.1620/tjem.169.187 8248911
13. Y Naito K Saito K Shiiba, et al. 1998 CD8+ T cells infiltrated within cancer cell nests as a prognostic factor in human colorectal cancer Cancer Res 58 3491 3494 1:CAS:528:DyaK1cXlsFajsb4%3D 9721846 (Pubitemid 28376536)
14. JR Jass 1986 Lymphocytic infiltration and survival in rectal cancer J Clin Pathol 39 585 589 1:STN:280:DyaL283ltFersA%3D%3D 10.1136/jcp.39.6.585 3722412 (Pubitemid 16069660)
15. L Zhang JR Conejo-Garcia D Katsaros, et al. 2003 Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer N Engl J Med 348 203 213 1:CAS:528:DC%2BD3sXksVehug%3D%3D 10.1056/NEJMoa020177 12529460 (Pubitemid 36077915)
16. S Aaltomaa P Lipponen M Eskelinen, et al. 1992 Lymphocyte infiltrates as a prognostic variable in female breast cancer Eur J Cancer 28A 859 864 1:STN:280:DyaK38zpvFSkug%3D%3D 10.1016/0959-8049(92)90134-N 1524909
17. S Menard G Tomasic P Casalini, et al. 1997 Lymphoid infiltration as a prognostic variable for early-onset breast carcinomas Clin Cancer Res 3 817 819 1:STN:280:DyaK1M7htFSjsQ%3D%3D 9815754 (Pubitemid 27244351)
18. IF Charo MB Taubman 2004 Chemokines in the pathogenesis of vascular disease Circ Res 95 858 866 1:CAS:528:DC%2BD2cXoslSksr4%3D 10.1161/01.RES. 0000146672.10582.17 15514167 (Pubitemid 39435000)
19. G Soria A Ben-Baruch 2008 The inflammatory chemokines CCL2 and CCL5 in breast cancer Cancer Lett 267 271 285 1:CAS:528:DC%2BD1cXovF2hsb0%3D 10.1016/j.canlet.2008.03.018 18439751
20. BH Rovin L Lu R Saxena 1999 A novel polymorphism in the MCP-1 gene regulatory region that influences MCP-1 expression Biochem Biophys Res Commun 259 344 348 1:CAS:528:DyaK1MXjs1Smu7g%3D 10.1006/bbrc.1999.0796 10362511 (Pubitemid 29281234)
21. C Fenoglio D Galimberti C Lovati, et al. 2004 MCP-1 in Alzheimer's disease patients: A-2518G polymorphism and serum levels Neurobiol Aging 25 1169 1173 1:CAS:528:DC%2BD2cXmslequrY%3D 10.1016/j.neurobiolaging.2003.11.008 15312962 (Pubitemid 39094019)
22. G Ghilardi ML Biondi A La Torre, et al. 2005 Breast cancer progression and host polymorphisms in the chemokine system: role of the macrophage chemoattractant protein-1 (MCP-1) -2518 G allele Clin Chem 51 452 455 1:CAS:528:DC%2BD2MXhtVGgs70%3D 10.1373/clinchem.2004.041657 15681563 (Pubitemid 40175819)
23. P Nahon A Sutton P Rufat, et al. 2007 Lack of association of some chemokine system polymorphisms with the risks of death and hepatocellular carcinoma occurrence in patients with alcoholic cirrhosis: a prospective study Eur J Gastroenterol Hepatol 19 425 431 1:CAS:528:DC%2BD2sXjvVaqtrc%3D 10.1097/MEG.0b013e3280120e2b 17413295 (Pubitemid 46596697)
24. P Nahon A Sutton P Rufat, et al. 2008 Chemokine system polymorphisms, survival and hepatocellular carcinoma occurrence in patients with hepatitis C virus-related cirrhosis World J Gastroenterol 14 713 719 1:CAS:528: DC%2BD1cXjsFyks7Y%3D 10.3748/wjg.14.713 18205260 (Pubitemid 351325053)
25. P Sáenz-López R Carretero JM Cózar, et al. 2008 Genetic polymorphisms of RANTES, IL1-A, MCP-1 and TNF-A genes in patients with prostate cancer BMC Cancer 8 382 10.1186/1471-2407-8-382 19099590
26. R Attar B Agachan SB Kuran, et al. 2010 Association of CCL2 and CCR2 gene variants with endometrial cancer in Turkish women In Vivo 24 243 248 1:CAS:528:DC%2BC3cXkvVClsrk%3D 20364004
27. LG Vázquez-Lavista G Lima F Gabilondo, et al. 2009 Genetic association of monocyte chemoattractant protein 1 (MCP-1)-2518 polymorphism in Mexican patients with transitional cell carcinoma of the bladder Urology 74 414 418 10.1016/j.urology.2009.04.016 19646633
28. KP Tse NM Tsang KD Chen, et al. 2007 MCP-1 promoter polymorphism at 2518 is associated with metastasis of nasopharyngeal carcinoma after treatment Clin Cancer Res 13 6320 6326 1:CAS:528:DC%2BD2sXht1Cgtb%2FO 10.1158/1078-0432.CCR-07- 1029 17975143 (Pubitemid 350075020)
29. Frierson HF Jr RA Wolber KW Berean, et al. 1995 Interobserver reproducibility of the Nottingham modification of the Bloom and Richardson histologic grading scheme for infiltrating ductal carcinoma Am J Clin Pathol 103 195 198
30. Sobin LH, Wittekind C (1997) TNM: classification of malignant tumors, 5th edn. Wiley-Liss, New York
31. CS Huang HD Chern KJ Chang, et al. 1999 Breast cancer risk associated with genotype polymorphism of the estrogen-metabolizing genes CYP17, CYP1A1, and COMT: a multigenic study on cancer susceptibility Cancer Res 59 4870 4875 1:CAS:528:DyaK1MXmslWktLw%3D 10519398
32. S Kim A Hagemann A DeMichele 2009 Immuno-modulatory gene polymorphisms and outcome in breast and ovarian cancer Immunol Investig 38 324 340 1:CAS:528:DC%2BD1MXpvV2jtLY%3D 10.1080/08820130902910567
33. A Carpi A Nicolini A Antonelli, et al. 2009 Cytokines in the management of high risk or advanced breast cancer: an update and expectation Curr Cancer Drug Targets 9 888 903 1:CAS:528:DC%2BC3cXhslKnsL0%3D 10.2174/156800909790192392 20025599
34. S Ali G Lazennec 2007 Chemokines: novel targets for breast cancer metastasis Cancer Metastasis Rev 26 401 420 1:CAS:528:DC%2BD2sXht1yktLbJ 10.1007/s10555-007-9073-z 17717637 (Pubitemid 350115103)
35. T Valković K Lucin M Krstulja, et al. 1998 Expression of monocyte chemotactic protein-1 in human invasive ductal breast cancer Pathol Res Pract 194 335 340 9651946 (Pubitemid 28291370)
36. V Goede L Brogelli M Ziche, et al. 1999 Induction of inflammatory angiogenesis by monocyte chemoattractant protein-1 Int J Cancer 82 765 770 1:CAS:528:DyaK1MXltFOitb8%3D 10.1002/(SICI)1097-0215(19990827)82:5<765::AID- IJC23>3.0.CO;2-F 10417778 (Pubitemid 29356979)
37. T Ueno M Toi H Saji, et al. 2000 Significance of macrophage chemoattractant protein-1 in macrophage recruitment, angiogenesis, and survival in human breast cancer Clin Cancer Res 6 3282 3289 1:CAS:528: DC%2BD3cXmsVOmt7c%3D 10955814 (Pubitemid 30637758)
38. H Saji M Koike T Yamori, et al. 2001 Significant correlation of monocyte chemoattractant protein-1 expression with neovascularization and progression of breast carcinoma Cancer 92 1085 1091 1:STN:280:DC%2BD3Mritl2isg%3D%3D 10.1002/1097-0142(20010901)92:5<1085::AID-CNCR1424>3.0.CO;2-K 11571719 (Pubitemid 32861655)
39. A Lebrecht C Grimm T Lantzsch, et al. 2004 Monocyte chemoattractant protein-1 serum levels in patients with breast cancer Tumour Biol 25 14 17 1:CAS:528:DC%2BD2cXksl2nsr4%3D 10.1159/000077718 15192307 (Pubitemid 38822766)
40. H Fujimoto T Sangai G Ishii, et al. 2009 Stromal MCP-1 in mammary tumors induces tumor-associated macrophage infiltration and contributes to tumor progression Int J Cancer 125 1276 1284 1:CAS:528:DC%2BD1MXovVelsLo%3D 10.1002/ijc.24378 19479998
41. M Mestdagt M Polette G Buttice, et al. 2006 Transactivation of MCP-1/CCL2 by beta-catenin/TCF-4 in human breast cancer cells Int J Cancer 118 35 42 1:CAS:528:DC%2BD2MXht1Kgsr3M 10.1002/ijc.21291 16003740 (Pubitemid 41681578)
42. M Takahashi H Miyazaki M Furihata, et al. 2009 Chemokine CCL2/MCP-1 negatively regulates metastasis in a highly bone marrow-metastatic mouse breast cancer model Clin Exp Metastasis 26 817 828 1:CAS:528:DC%2BD1MXhsVWls77J 10.1007/s10585-009-9281-8 19629725
43. T Valković D Fuckar S Stifter, et al. 2005 Macrophage level is not affected by monocyte chemotactic protein-1 in invasive ductal breast carcinoma J Cancer Res Clin Oncol 131 453 458 10.1007/s00432-004-0667-3 15883814 (Pubitemid 40905023)
44. A Galvan JP Ioannidis TA Dragani 2010 Beyond genome-wide association studies: genetic heterogeneity and individual predisposition to cancer Trends Genet 26 132 141 1:CAS:528:DC%2BC3cXit1OntLk%3D 10.1016/j.tig.2009.12.008 20106545